Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
FDA Approvals, News & Updates
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
FDA Will Require Early Assessment of New Targeted Agents That May Be Used in Pediatric Cancers
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
Recap of FDA Drug Approvals in 2019
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
FDA Grants Approval to Avapritinib for Patients with GIST
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
November 11, 2019 — Oncology News & Updates
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
October 28, 2019 – Oncology News & Updates
FDA Approvals, News & Updates
,
Ovarian Cancer
Read More ›
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Breast Cancer
,
Pediatric Oncology
,
Multiple Myeloma
,
FDA Approvals, News & Updates
Read More ›
Page 1 of 3
1
2
3